MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

Glioblastoma is the most malignant central nervous system tumor, which represents 50% of all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment planning has been significantly enhanced by the discovery of molecular genetic biomarkers. This study aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Szylberg, Mateusz, Sokal, Paweł, Śledzińska, Paulina, Bebyn, Marek, Krajewski, Stanisław, Szylberg, Łukasz, Szylberg, Aneta, Szylberg, Tadeusz, Krystkiewicz, Kamil, Birski, Marcin, Harat, Marek, Włodarski, Robert, Furtak, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405779/
https://www.ncbi.nlm.nih.gov/pubmed/36009577
http://dx.doi.org/10.3390/biomedicines10082030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405779/
https://www.ncbi.nlm.nih.gov/pubmed/36009577
http://dx.doi.org/10.3390/biomedicines10082030

Ejemplares similares